But for patients with inflammatory arthritis, a range of systemic diseases involving ... In most cases, if the patient is having problems in the shoulder, elbow, hand and wrist, Dr. Figgie treats the ...

In a significant advancement for hand rehabilitation, researchers from Zhengzhou University have introduced a non-hand-worn, ...

We walked into our hands-on preview expecting to miss the OLED display but walked out completely satisfied with the Switch 2’s LCD, so it’s not the end of the world for Nintendo fans.

I guess I sorta suspected the day would come when my inner despot would awaken to wreak havoc on the galaxy, but I was surprised just how quickly it went down, after just a few minutes with the ...

A rheumatologist arms you with her best advice for treating this chronic arthritis. Be honest with your doctor, and don’t downplay your symptoms. See how this hand and finger disease affects ...

Autoimmune arthritis, where the immune system attacks joints, presents early signs like morning stiffness exceeding 30 minutes, swollen and warm joints, and unexplained fatigue. Difficulty moving ...

The CBD creams we’ve found to be most effective for pain tend to have other ingredients that create a cooling sensation for pain relief. It’s hard to say which ingredient is offering the bulk ...

But it may also lead to conditions that cause joint pain, such as arthritis. Research suggests that up to 46% of people with IBD experience joint pain, according to Crohn’s and Colitis UK.

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

There are many possible causes of hip pain, ranging from muscle strains and injuries to arthritis and other inflammatory ... of the feet together. Place a hand on top of each knee and gently ...

They say Granny really did know best when she insisted on a daily dose, because it halts the inflammation and destruction of joint cartilage caused by arthritis. And they believe supplements could ...

Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class ...